Nonsteroidal anti-inflammatory analgesics and gastrointestinal protection in palliative care patients

Dickman A , Ellershaw J. NSAIDs: gastroprotection or selective COX-2 inhibitor? Palliat Med 2004; 18: 275–286 .

Seager JM , Hawkey CJ . ABC of the upper gastrointestinal tract. Indigestion and non-steroidal anti-inflammatory drugs . Br Med J 2001; 323: 1236–1239 .

Mamdani M , Juurlink DN , Kopp A , Naglie G , Austin PC , Laupacis A. Gastrointestinal bleeding after introduction of COX-2 inhibitors: ecological study . Br Med J 2004; 328: 1415–1416 .

Bombardier C , Laine L , Reicin A , et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. The VIGOR Study Group . N Engl J Med 2000; 343: 1520–1528 .

Lisse JR , Perlman M , Johansson G , et al. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in treatment of osteoarthritis . Ann Intern Med 2003; 139: 539–546 .

Langman MJ , Jensen DM , Watson DJ , et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs . J Am Med Assoc 1999; 282: 1929–1933 .

Dalton SO , Johansen C , Mellemkjoer L , Nørgard B , Sørensen HT , Jørgen HO . Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population based cohort study . Arch Intern Med 2003; 163: 59–64 .

Chan FKL , Hung LCT , Suen BY , et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis . N Engl J Med 2002; 347: 2104–2110 .